Neurocrine Biosciences
NBIX
#1526
Rank
โ‚ฌ11.06 B
Marketcap
110,93ย โ‚ฌ
Share price
1.62%
Change (1 day)
-9.57%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : โ‚ฌ1.07 Billion

According to Neurocrine Biosciences 's latest financial reports the company's total liabilities are โ‚ฌ1.07 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Neurocrine Biosciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ0.92 B49.67%
2022-12-31โ‚ฌ0.61 B-0.11%
2021-12-31โ‚ฌ0.61 B24.67%
2020-12-31โ‚ฌ0.49 B-17.17%
2019-12-31โ‚ฌ0.59 B33.36%
2018-12-31โ‚ฌ0.44 B20.64%
2017-12-31โ‚ฌ0.37 B677.76%
2016-12-31โ‚ฌ47.73 M3.7%
2015-12-31โ‚ฌ46.03 M63.06%
2014-12-31โ‚ฌ28.23 M13.78%
2013-12-31โ‚ฌ24.81 M-21.12%
2012-12-31โ‚ฌ31.45 M-47.82%
2011-12-31โ‚ฌ60.28 M-35.89%
2010-12-31โ‚ฌ94.03 M101.49%
2009-12-31โ‚ฌ46.66 M-19.86%
2008-12-31โ‚ฌ58.23 M-46.17%
2007-12-31โ‚ฌ0.10 B90.43%
2006-12-31โ‚ฌ56.81 M-27.65%
2005-12-31โ‚ฌ78.52 M-15.05%
2004-12-31โ‚ฌ92.43 M-28.97%
2003-12-31โ‚ฌ0.13 B221.7%
2002-12-31โ‚ฌ40.45 M-0.65%
2001-12-31โ‚ฌ40.71 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ0.77 B-27.90%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ7.52 B 597.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ10.6 M-99.02%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ58.55 B 5,328.36%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ131.22 B 12,065.72%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ121.25 B 11,141.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.81 B-24.13%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ41.86 M-96.12%๐Ÿ‡บ๐Ÿ‡ธ USA